- Accelerating collaboration as a prime AI solution at the onset of lung cancer screening across Europe
Coreline Soft is enhancing its dominance in the AI remote diagnosis market after strengthening its position last year with the UK-based teleradiology company DMC Healthcare. On the 20th, Coreline Soft announced that it has signed a supply contract for its proprietary AI software with XCoorp GMBH, a remote diagnosis company based in Europe.
This contract was finalized after XCoorp requested the supply of AI software from Coreline Soft due to a rapid increase in local demand for remote diagnosis in Europe. XCoorp is an Austria-based specialist in remote diagnosis and AI-based imaging diagnostics. The company has a network of numerous hospitals and radiology centers throughout Europe and is collaborating with medical AI firms in Austria, Germany, Belgium, and Japan.
With this contract, Coreline Soft plans to accelerate its strategy in the global remote diagnosis market. The company has recently proven its superior AI technology compared to the world’s top imaging diagnostic companies through international journals and has developed products that integrate the workflows of remote diagnosis companies with AI software, which is expected to expand adoption.
The global remote diagnosis market is rapidly growing, particularly in North America and Europe, due to a shortage of medical personnel and advancements in AI technology that have increased the demand for image reading. According to market research firm Grand View Research, the global market size was $15.6 billion (approximately 22 trillion won) last year and is projected to grow at a compound annual growth rate of 25.7% to reach $60.3 billion (approximately 87 trillion won) by 2030.
A representative from Coreline Soft stated, “Following our first contract in the remote diagnosis field with DMC Healthcare last year, securing references for European government projects and proving our AI technology through research papers has accelerated the adoption among remote diagnosis companies. Due to a confidentiality agreement, we cannot disclose the specific details of the contract, but it is significant that the unit price has more than doubled compared to previous contracts, demonstrating Coreline Soft's AI technology's global competitiveness.”
He added, “From this contract, we plan to continue our collaboration with XCoorp, expanding the application of solutions and AI software usage. Moreover, based on the recently launched AI platform, we will enhance our AI technology to accelerate our strategy in the global remote diagnosis market.”
